Effect of the premalignant and tumor microenvironment on immune cell cytokine production in head and neck cancer.
about
An Inflammatory Cytokine Milieu is Prominent in Premalignant Oral Lesions, but Subsides when Lesions Progress to Squamous Cell Carcinoma.Distinct Transcriptional Changes and Epithelial-Stromal Interactions Are Altered in Early-Stage Colon Cancer DevelopmentCytokine and Adipokine Levels in Patients with Premalignant Oral Lesions or in Patients with Oral Cancer Who Did or Did Not Receive 1α,25-Dihydroxyvitamin D3 Treatment upon Cancer Diagnosis.Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agentThe hallmarks of premalignant conditions: a molecular basis for cancer preventionIndomethacin Treatment of Mice with Premalignant Oral Lesions Sustains Cytokine Production and Slows Progression to Cancer.Premalignant Oral Lesion Cells Elicit Increased Cytokine Production and Activation of T-cells.Reversal effect and mechanism of Ginkgo biloba exocarp extracts in multidrug resistance of mice S180 tumor cells.Alteration in Taste Perception in Cancer: Causes and Strategies of TreatmentElucidating drivers of oral epithelial dysplasia formation and malignant transformation to cancer using RNAseq.Th17 Cells in Protection from Tumor or Promotion of Tumor ProgressionRedirecting the focus of cancer immunotherapy to premalignant conditions.Role of T helper 17 cytokines in the tumour immune inflammation response of patients with laryngeal squamous cell carcinoma.Treatment to sustain a Th17-type phenotype to prevent skewing toward Treg and to limit premalignant lesion progression to cancer.
P2860
Q34556117-1EFE2A9F-46FB-44B4-A802-8AC9B7CFC59DQ36063498-783393DB-CECD-47C6-A2A5-EDCB0EF4C6D4Q36102797-F1B64E81-DE05-4DE5-AFC0-529847F304EBQ36483712-AF8BA4D6-05C7-4289-911B-308A517B4582Q36679858-F77FBACE-B99F-43D6-B7A5-6C6B6DE45CCBQ37273566-E64074AB-38F0-43C5-B3BB-2CEC32EBCC4CQ37274307-0B1B7BB5-5863-492C-A773-0CC739905D13Q37289376-8ED83B2E-C6C5-4051-A469-779C82D9BC49Q37685359-56435694-6C82-4E3A-88E5-958CFA29F3F9Q38261799-1710C445-ED8B-4A4A-AA5D-FB962CC55A96Q38907336-F877AB8B-F4AD-449E-BA80-DC56E69640E7Q39107022-66AE4480-0EFC-4C2F-9510-22E2BA6E5960Q40979257-B7B16619-A739-4DBD-992E-880502871F13Q55295766-59CF779B-3D26-4C92-9C74-085080E7538B
P2860
Effect of the premalignant and tumor microenvironment on immune cell cytokine production in head and neck cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Effect of the premalignant and ...... ction in head and neck cancer.
@ast
Effect of the premalignant and ...... ction in head and neck cancer.
@en
type
label
Effect of the premalignant and ...... ction in head and neck cancer.
@ast
Effect of the premalignant and ...... ction in head and neck cancer.
@en
prefLabel
Effect of the premalignant and ...... ction in head and neck cancer.
@ast
Effect of the premalignant and ...... ction in head and neck cancer.
@en
P2093
P2860
P356
P1433
P1476
Effect of the premalignant and ...... ction in head and neck cancer.
@en
P2093
Anna-Maria A De Costa
M Rita I Young
Sara D Johnson
P2860
P304
P356
10.3390/CANCERS6020756
P577
2014-04-02T00:00:00Z